Clinical Trial Update: Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit [Phase 3]

View source ↗

Summary

The update covers a Phase 3 clinical trial evaluating methylnaltrexone for treating opioid-induced constipation in ICU patients. Sponsor: St. John Health System…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Methylnaltrexone (Relistor) (methylnaltrexone)

Snippet

Sponsor: St. John Health System, Michigan | Conditions: Opioid-induced Constipation | Phase 3 | Status: UNKNOWN